解开胃癌中调节性细胞死亡途径:一项多omics研究
Jiazheng Sun1, Lixiang Rao1, Sirui Zhou1
1Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Frontiers in pharmacology
|September 24, 2024
概括
一个新的调节性细胞死亡指数 (RCDI) 签名准确地预测胃癌存活率. 这种RCDI签名也与免疫活性相关,为改善患者的治疗结果提供了一个有希望的工具.
科学领域:
- 在瘤学瘤学.
- 癌症研究 癌症研究
- 免疫学 免疫学 免疫学
背景情况:
- 胃癌 (GC) 是全球癌症死亡的主要原因,其5年生存率很低.
- GC逃避调节性细胞死亡 (RCD) 的能力是关键特征,但其临床意义仍未得到充分探索.
研究的目的:
- 开发和验证一种新的调节性细胞死亡指数 (RCDI) 签名,用于胃癌.
- 在GC患者中评估RCDI签名的预后价值和临床意义.
主要方法:
- 利用101个机器学习算法对来自6个队伍的1292名GC患者的表达数据进行分析.
- 根据已识别的调节性细胞死亡模式开发了一个RCDI签名.
- 与现有的生物标志物对比,验证了RCDI签名的预测准确性.
主要成果:
- 该RCDI签名证明了强大的和可靠的预后能力为GC患者的生存.
- RCDI精度超过了之前报告的20个预后签名的精度.
- RCDI与免疫细胞透,免疫治疗标记物和与免疫相关的功能有显著的关联,这表明免疫活性升高.
结论:
- 该RCDI签名作为胃癌的强大和令人鼓舞的生物标志物.
- RCDI有可能增强个性化治疗策略,并改善GC患者的临床结果.
相关概念视频
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K


